Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum, ...

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm ...

Barclays (LON:BARC) adjusted the firm's stance on Netflix (NASDAQ:NFLX) stock, upgrading it from Underweight to Equalweight ...

Barclays (LON:BARC) reaffirmed its positive stance on Replimune Group (NASDAQ:REPL), maintaining an Overweight rating and a $17.00 price target, representing significant upside from the current price ...

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong ...

Barclays (LON:BARC) analyst Nicholas Campanella revised the price target for Edison International (NYSE:EIX) shares, reducing ...

In a report released today, Raimo Lenschow from Barclays maintained a Buy rating on Sprout Social (SPT – Research Report), with a price target ...

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where ...

Marvell Technology (NASDAQ:MRVL) and Nvidia (NASDAQ:NVDA) arise as leaders in artificial intelligence semiconductor firms in ...